Incretin Mimetics

Incretin mimetics such as DDP-4 inhibitors and GLP-1 receptor agonists stimulate insulin release when glucose is absorbed after eating. Incretins also decrease gastric emptying and cause weight loss.

​

Please consult your doctor for any advice on usage of medication to manage diabetes.

​

Dipeptidyl peptidase 4 (DPP-4) inhibitors

​

DDP-4 inhibitors such as sitagliptin and vidagliptin decrease the amount of fat in your blood after eating.

​

DDP-4 inhibitors have been demonstrated to improve cardiac function in diabetic patients.

​

Potential adverse effects of DDP-4 inhibitors include nasopharyngitis, upper respiratory tract infection and headache.

​

Please consult your doctor for any advice on usage of medication to manage diabetes.

​

Glucagon-like peptide-1 (GLP-1) receptor agonists

​

GLP-1 receptor agonists include exenatide and liraglutide.

​

Most common side effect of exenatide is nausea. Exenatide should not be used in patients with severe renal impairment or end-stage renal disease.

​

Side effects of liraglutide include headache, constipation, tiredness heartburn, difficulty urinating or pain or burning on urination.

​

Please consult your doctor for any advice on usage of medication to manage diabetes.